The ligand that binds to TNFR1 is TNF-α, an early phase inflammatory cytokine that has been hypothesized to be a key mediator of AD pathology based on studies in mice (McAlpine et al., 2009) and humans (Wang et al., 2018). This evidence concerns the gene TNF and Alzheimer disease.